Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer Article Proceedings Paper

Industry Collaboration

cited authors

  • Socinski, Mark A.; Raju, Robert N.; Stinchcombe, Thomas; Kocs, Darren M.; Couch, Linda S.; Barrera, David; Rousey, Steven R.; Choksi, Janak K.; Jotte, Robert; Patt, Debra A.; Periman, Phillip O.; Schlossberg, Howard R.; Weissman, Charles H.; Wang, Yunfei; Asmar, Lina; Pritchard, Sharon; Bromund, Jane; Peng, Guangbin; Treat, Joseph; Obasaju, Coleman K.

authors

Publication Date

  • December 1, 2010

webpage

published in

category

keywords

  • Carboplatin
  • Enzastaurin
  • NSCLC
  • Pemetrexed
  • Randomized phase II trial

start page

  • 1963

end page

  • 1969

volume

  • 5

issue

  • 12